Key result
Decreased or defective signaling in the TGF-β pathway is likely responsible for the development of both a bicuspid aortic valve and an abnormal ascending aortic wall susceptible to complications.
Why the study?
BAV is highly prevalent and carries an increased risk of thoracic aortic aneurysm and dissection, placing a considerable burden on public health.
This review highlights the role of transforming growth factor beta (TGF-β) signaling in vascular wall development and its potential involvement in thoracic aortic aneurysm formation in patients with bicuspid and tricuspid aortic valves.
Highlights TGF-β pathway in BAV aortopathy risk stratification; leaves open therapeutic targeting pending prospective studies.
A bicuspid aortic valve (BAV) is the most prevalent congenital cardiac deformity, which is associated with an increased risk to develop a thoracic aortic aneurysm and/or an aortic dissection as compared to persons with a tricuspid aortic valve. Due to the high prevalence of a BAV in the general population and the associated life-long increased risk for adverse vascular events, BAV disease places a considerable burden on the public health. The aim of the present review is to discuss the role of transforming growth factor beta (TGF-β) signaling in the development of the vascular wall and on how this complex signaling pathway may be involved in thoracic aortic aneurysm formation in tricuspid and BAV patients.
No takes yet. Share an insight, caveat, or question.
Grewal et al. (2023) conducted a review in Bicuspid aortic valve aortopathy. Transforming growth factor beta (TGF-β) signaling was evaluated. Decreased or defective signaling in the TGF-β pathway is likely responsible for the development of both a bicuspid aortic valve and an abnormal ascending aortic wall susceptible to complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: